Life Sciences

BullFrog AI Holdings, Inc., a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and...

New Clinical AI care suites for Cardiology, Pulmonology, and Neurology; First-in-Class multi-modal predictive and Gen AI platform for research and clinical model development. ConcertAI's TeraRecon,...

Curia, a leading contract research, development and manufacturing organization, announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26. Lavezoli...

Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, announced the appointment of Gregory Cole, PhD as Chief Innovation...

Evaxion Biotech A/S, a clinical research-focused biotechnology company specializing in the development of vaccines powered by AI-Immunology™, announces the success of the initial phases...

Absci Corporation, a data-first generative AI drug creation company, announced the initiation of IND-enabling studies for ABS-101, a potential best-in-class anti-TL1A antibody designed using...

ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, announced the successful initial use of its Artificial...

Transformative, instrument-free solution for single cell RNA sequencing updated with improved sensitivity, faster workflow Parse Biosciences, a leading provider of accessible and scalable single cell sequencing...

The research demonstrates a breakthrough in applying quantum-enhanced generative AI to drug discovery using today’s quantum devices. Zapata Computing, Inc., the Industrial Generative AI company,...

AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, and German independent research institute BioMed X,...